IPI Intrepid Potash, Inc.
Intrepid Potash, Inc. delivers potassium, magnesium, sulfur, salt, and water products. It operates through three segments: Potash, Trio, and Oilfield Solutions. The company offers muriate of potash for various markets, such as in agricultural market as a fertilizer input, in animal feed market as a nutrient supplement, in industrial market as a component in drilling and fracturing fluids, as well as input to other industrial processes. It also provides Trio, a specialty fertilizer that delivers potassium, sulfate, and magnesium in a single particle; salt for various markets, including animal feed, industrial applications, pool salt, and the treatment of roads and walkways for ice melting or to manage road conditions; magnesium chloride for use as a road treatment agent for deicing and dedusting; brines for use in oil and gas industry to support well workover and completion activities; and metal recovery salts. The company was founded in 2000 and is based in Denver, Colorado.…
Industry Peers
Agricultural InputsKey Statistics
About Intrepid Potash (NYSE: IPI)
›
Intrepid Potash (NYSE: IPI) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Agricultural Inputs industry, part of the Basic Materials sector, and reports about 478 employees.
The shares were at 29.50 USD on 19 November 2026, up 12.6% over 52 weeks. Its 52-week range is 24.12 USD to 50.34 USD: the price is 41.4% below the high and 22.3% above the low.
At a market capitalisation of 394.25M USD, it trades at 36.9 times trailing earnings and 30.4 times forward earnings. The median trailing P/E of its 12 largest Agricultural Inputs peers is 10.1, a premium of 266% for IPI.
Intrepid Potash reports return on equity of 2.3%, an operating margin of 8.5% and revenue down 1.3% year over year.
It holds more cash than debt, a net cash position of 158.57M USD. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 2 analysts cover the stock, with an average rating of Underperform; their mean price target of 34.50 USD is 16.9% above the current price. The next earnings report is expected on 3 March 2027.